Borderline Resectable Pancreatic Ductal Adenocarcinoma Clinical Trials in Buffalo, New York

NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial